Poll: Do You Agree with the FDA's Decision to Pull Avastin?

Article

This week the FDA pulled its accelerated approval of Avastin for women with HER2-negative metastatic breast cancer who have not undergone chemotherapy.

Everyone wants the best treatment available when it comes to cancer, breast cancer is no different. This week the FDA pulled its accelerated approval of Avastin for women with HER2-negative metastatic breast cancer who have not undergone chemotherapy. Avastin is still available for other types of cancer but because it is no longer approved for breast cancer insurance companies will not cover the approximately $8000.00 per month it costs. This puts breast cancer treatment out of reach for many women who say this was working for them.

Newsletter

Get the latest clinical updates, case studies, and expert commentary in obstetric and gynecologic care. Sign up now to stay informed.

Subscribe Now!
Recent Videos
Neal Barnard, MD, FACC, highlights AMA's new breast cancer prevention guidelines | Image Credit: pcrm.org.
Zachary Wagner, PhD, discusses the harms of bias in reproductive care | Image Credit: ornsife.usc.edu.
Ciera Kirkpatrick, PhD, shows how TikTok is transforming cervical cancer awareness | Image Credit: linkedin.com.
Maria Gallo, PhD, discusses high attendance at crisis pregnancy centers | Image Credit: © x.com.
Related Content
Postpartum hemorrhage linked to long-term heart and blood clot risks | Image Credit: © Syda Productions - © Syda Productions - stock.adobe.com.

Postpartum hemorrhage linked to long-term heart and blood clot risks

Celeste Krewson, Assistant Editor
June 27th 2025
Article

A new study finds women with postpartum hemorrhage face significantly higher odds of cardiovascular disease and thromboembolism for up to 15 years after childbirth.

Read More

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Pap Talk S4E15: MIRA surgical system for hysterectomy with Jean Dubuisson, MD, PhD

Celeste Krewson, Assistant Editor
December 31st 2024
Podcast

In this episode of Pap Talk, Jean Dubuisson, MD, PhD, discusses the first successful hysterectomy performed using the MIRA surgical system.

Listen

Breast cancer incidence trends vary by age, race, and stage in older women | Image Credit: © vectorfusionart - © vectorfusionart - stock.adobe.com.

Breast cancer incidence trends vary by age, race, and stage in older women

Celeste Krewson, Assistant Editor
June 26th 2025
Article

A new study reveals rising breast cancer rates among minority women aged 65 to 74 years, highlighting the need for targeted screening and intervention strategies.

Read More

Site Logo

How Individually Identifying More HPV Types Enables Better Patient Management and More Precise Care

September 29th 2023
Podcast

Listen

Rising postpartum hemorrhage linked to higher costs and SMM | Image Credit: © Meeko Media - © Meeko Media - stock.adobe.com.

Rising postpartum hemorrhage linked to higher costs and SMM

Celeste Krewson, Assistant Editor
June 25th 2025
Article

A new study reveals that abnormal postpartum bleeding is more common than previously reported, driving up hospital costs and increasing the risk of serious complications.

Read More

Oral sulopenem demonstrates non-inferiority to amoxicillin/clavulanate in phase 3 uUTI trial | Image Credit: © valiantsin - stock.adobe.com.

Oral sulopenem demonstrates non-inferiority to amoxicillin/clavulanate in phase 3 uUTI trial

Morgan Ebert, Managing Editor
June 25th 2025
Article

Oral sulopenem (ORLYNVAH; Iterum Therapeutics) was non-inferior to amoxicillin/clavulanate for treating uUTIs in women, per the phase 3 REASSURE trial.

Read More

© 2025 MJH Life Sciences

All rights reserved.